Design Therapeutics Inc (DSGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 19,311 | 21,569 | 20,418 | 16,694 | 16,246 |
| Operating Income | -19,311 | -21,569 | -20,418 | -16,694 | -16,246 |
| Other Income | 2,314 | 2,486 | 2,703 | 3,043 | 3,207 |
| Pre-tax Income | -16,997 | -19,083 | -17,715 | -13,651 | -13,039 |
| Net Income Continuous | -16,997 | -19,083 | -17,715 | -13,651 | -13,039 |
| Net Income | $-16,997 | $-19,083 | $-17,715 | $-13,651 | $-13,039 |
| EPS Basic Total Ops | -0.30 | -0.34 | -0.31 | -0.24 | -0.23 |
| EPS Basic Continuous Ops | -0.30 | -0.34 | -0.31 | -0.24 | -0.23 |
| EPS Diluted Total Ops | -0.30 | -0.34 | -0.31 | -0.24 | -0.23 |
| EPS Diluted Continuous Ops | -0.30 | -0.34 | -0.31 | -0.24 | -0.23 |
| EPS Diluted Before Non-Recurring Items | -0.30 | -0.34 | -0.31 | -0.24 | -0.23 |
| EBITDA(a) | $-19,923 | $-22,331 | $-21,319 | $-17,983 | $-17,549 |